{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:50:58Z","timestamp":1761393058571,"version":"3.43.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1023\/a:1021189128084","type":"journal-article","created":{"date-parts":[[2003,3,20]],"date-time":"2003-03-20T19:40:25Z","timestamp":1048189225000},"page":"135-141","source":"Crossref","is-referenced-by-count":10,"title":["Knowledge about breast cancer risk factors and hereditary breast cancer among early-onset breast cancer survivors"],"prefix":"10.1007","volume":"1","author":[{"given":"Susan","family":"Miesfeldt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Ropka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5098361_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3322\/canjclin.52.1.23","volume":"52","author":"A Jemal","year":"2002","unstructured":"Jemal A, Thomas A, Murray T, Thun M. Cancer statistics 2002. Can Cancer J Clin 2002; 52: 23-47.","journal-title":"Can Cancer J Clin"},{"key":"5098361_CR2","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","volume":"77","author":"EB Claus","year":"1996","unstructured":"Claus EB, Schildkaraut JM, Thompson WD et al. The genetic attributable risk of breast and ovarian cancer. Cancer 1996; 77: 2318-24.","journal-title":"Cancer"},{"key":"5098361_CR3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.med.52.1.371","volume":"52","author":"C Eng","year":"2000","unstructured":"Eng C, Hampel H, de la Chapelle A. Genetic testing for cancer predisposition. Annu Rev Med 2000; 52: 371-400.","journal-title":"Annu Rev Med"},{"key":"5098361_CR4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0093-7754(01)90134-4","volume":"28","author":"P Ang","year":"2001","unstructured":"Ang P, Garber JE. Genetic susceptibility for breast cancer-risk assessment and counseling. Semin Oncol 2001; 28: 419-33.","journal-title":"Semin Oncol"},{"key":"5098361_CR5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(97)07065-7","volume":"351","author":"LC Verhoog","year":"1998","unstructured":"Verhoog LC, Brekelmans CTM, Seynaeve C et al. Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 1998; 351: 316-21.","journal-title":"Lancet"},{"key":"5098361_CR6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","volume":"343","author":"D Ford","year":"1994","unstructured":"Ford D, Easton DF, Bishop DT et al. Risks of cancer in BRCA1-mutation carriers. Lancet 1994; 343: 692-5.","journal-title":"Lancet"},{"key":"5098361_CR7","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1200\/JCO.1999.17.11.3396","volume":"17","author":"LC Verhoog","year":"1999","unstructured":"Verhoog LC, Brekelmans CTM, Seynaeve C et al. Survival in hereditary breast cancer associated with germline mutations of BRCA2. J Clin Oncol 1999; 17: 3396-402.","journal-title":"J Clin Oncol"},{"key":"5098361_CR8","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","volume":"15","author":"The Breast Cancer Linkage Consortium.","year":"1999","unstructured":"The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 1999; 15: 1310-6.","journal-title":"J Natl Cancer Inst"},{"key":"5098361_CR9","first-page":"267","volume":"56","author":"DF Easton","year":"1995","unstructured":"Easton DF, Bishop DT, Ford D et al. Breast and ovarian cancer incidence in BRCA1 mutation carriers. Am J Hum Genet 1995; 56: 267-71.","journal-title":"Am J Hum Genet"},{"key":"5098361_CR10","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","volume":"336","author":"JP Struewing","year":"1997","unstructured":"Struewing JP, Hartge P, Wacholder S et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336: 1401-8.","journal-title":"N Engl J Med"},{"key":"5098361_CR11","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/318181","volume":"68","author":"D Thompson","year":"2001","unstructured":"Thompson D, Easton D, on behalf of the Breast Cancer Linkage Consortium. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 2001; 68: 410-9.","journal-title":"Am J Hum Genet"},{"key":"5098361_CR12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/jnci\/89.2.148","volume":"89","author":"C Lerman","year":"1997","unstructured":"Lerman C, Biesecker B, Benkendorf JL et al. Controlled trial of pretest education approaches to enhance informed decisionmaking for BRCA1 testing. J Natl Cancer Inst 1997; 89: 148-57.","journal-title":"J Natl Cancer Inst"},{"key":"5098361_CR13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1525-1500.1999.00065.x","volume":"23","author":"J Mouchawar","year":"1999","unstructured":"Mouchawar J, Byers T, Cutter G et al. A study of the relationship between family history of breast cancer and knowledge of breast cancer genetic testing prerequisites. Cancer Detect Prev 1999; 23: 22-30.","journal-title":"Cancer Detect Prev"},{"key":"5098361_CR14","first-page":"158","volume":"2","author":"EJ Ludman","year":"1999","unstructured":"Ludman EJ, Curry SJ, Hoffman E et al. Women's knowledge and attitudes about genetic testing for breast cancer susceptibility. Eff Clin Pract 1999: 2; 158-62.","journal-title":"Eff Clin Pract"},{"key":"5098361_CR15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0738-3991(97)00064-5","volume":"32","author":"C Hughes","year":"1997","unstructured":"Hughes C, Gomez-Caminero A, Benkendorf J et al. Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns 1997; 32: 51-62.","journal-title":"Patient Educ Couns"},{"key":"5098361_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1023\/A:1005416203239","volume":"23","author":"KA Donovan","year":"2000","unstructured":"Donovan KA, Tucker DC. Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a sociodemographically diverse sample. J Behav Med 2000; 23: 15-36.","journal-title":"J Behav Med"},{"key":"5098361_CR17","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1200\/JCO.1999.17.3.1040","volume":"17","author":"LG Bluman","year":"1999","unstructured":"Bluman LG, Rimer BK, Berry DA et al. Attitudes, Knowledge and risk perceptions of women with breast and\/or ovarian cancer considering testing for BRCA1 and BRCA2. J Clin Oncol 1999; 17: 1040-6.","journal-title":"J Clin Oncol"},{"key":"5098361_CR18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1445-5994.2001.00091.x","volume":"31","author":"J Randall","year":"2001","unstructured":"Randall J, Butwo P, Kirk J et al. Psychological impact of genetic counselling and testing in women previously diagnosed with breast cancer. Int Med J 2001; 31: 397-405.","journal-title":"Int Med J"},{"key":"5098361_CR19","volume-title":"Mail and Telephone Surveys: The Total Design Method","author":"DA. Dillman","year":"1978","unstructured":"Dillman DA. Mail and Telephone Surveys: The Total Design Method. New York: John Wiley and Sons, 1978."},{"key":"5098361_CR20","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jama.1997.03540360065034","volume":"277","author":"W Burke","year":"1997","unstructured":"Burke W, Daly M, Garber J et al. Recommendations for followup care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. JAMA 1997; 277: 997-1003.","journal-title":"JAMA"},{"key":"5098361_CR21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","volume":"340","author":"LC Hartmann","year":"1999","unstructured":"Hartmann LC, Schaid DJ, Woods JE et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999; 340: 77-84.","journal-title":"N Engl J Med"},{"key":"5098361_CR22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","volume":"345","author":"H Meijers-Heijboer","year":"2001","unstructured":"Meijers-Heijboer H, van Geel B, van Putten WLJ et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2001; 345: 159-64.","journal-title":"N Engl J Med"},{"key":"5098361_CR23","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","volume":"93","author":"LC Hartmann","year":"2001","unstructured":"Hartmann LC, Sellers TA, Schaid DJ et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 2001; 93: 1633-7.","journal-title":"J Natl Cancer Inst"},{"key":"5098361_CR24","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/jnci\/91.17.1475","volume":"91","author":"TR Rebbeck","year":"1999","unstructured":"Rebbeck TR, Levin AM, Eisen A et al. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 1999; 91: 1475-9.","journal-title":"J Natl Cancer Inst"},{"key":"5098361_CR25","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1200\/JCO.2000.18.9.1980","volume":"18","author":"A Eisen","year":"2000","unstructured":"Eisen A, Rebbeck TR, Wood W, Weber B. Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol 2000; 18: 1980-95.","journal-title":"J Clin Oncol"},{"key":"5098361_CR26","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(00)03258-X","volume":"356","author":"SA Narod","year":"2000","unstructured":"Narod SA, Brunet JS, Ghadirian P et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Lancet 2000; 356: 1876-81.","journal-title":"Lancet"},{"key":"5098361_CR27","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","volume":"286","author":"MC King","year":"2001","unstructured":"King MC, Wieand S, Hale K et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2. JAMA 2001; 286: 2251-5.","journal-title":"JAMA"},{"key":"5098361_CR28","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/jama.1996.03530480027036","volume":"275","author":"C Lerman","year":"1996","unstructured":"Lerman C, Narod S, Schulman K et al. BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes. JAMA 1996; 275: 1885-92.","journal-title":"JAMA"},{"key":"5098361_CR29","volume-title":"Final Report","author":"KA Luker","year":"1993","unstructured":"Luker KA, Leinster S, Owens G et al. Preferences for Information and Decision Making in Women with Newly Diagnosed Breast Cancer. Final Report. London: Cancer Macmillan Fund, 1993."},{"key":"5098361_CR30","volume-title":"Research Report","author":"L. Degner","year":"1994","unstructured":"Degner L. Boman D. Kristjanson L et al. Profiles of Information Needs in Women with Breast Cancer: Cross Cultural Comparisons. Research Report. Winnipeg: University of Manitoba, 1994."},{"key":"5098361_CR31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00002820-199606000-00007","volume":"19","author":"K Chalmers","year":"1996","unstructured":"Chalmers K, Thomson K, Degner L. Information, support and communication needs of women with a family history of breast cancer. Cancer Nurs 1996; 19: 204-13.","journal-title":"Cancer Nurs"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1021189128084.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1021189128084\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1021189128084.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T04:21:50Z","timestamp":1754367710000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1021189128084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":31,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["5098361"],"URL":"https:\/\/doi.org\/10.1023\/a:1021189128084","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"type":"print","value":"1389-9600"},{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}